3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Classical hematology
1
Conditions
Stomach Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Anemia, Iron-Deficiency
1
Anemia
1
Adenocarcinoma
1
Interventions
ferric carboxymaltose
2
Pemetrexed
2
Drug Therapy
2
iron isomaltoside 1000
1
icotinib
1
ferrous sulfate
1
elemene
1
aumolertinib
1
aflutinib
1
Rabeprazole
1
Gemcitabine
1
Docetaxel
1
Desflurane
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Adenocarcinoma
×
iron isomaltoside 1000
×
Clear all
NCT01927328
2016-10-28
IRON
Nottingham University Hospitals NHS Trust
Phase 4
Unknown
40 enrolled